AstraZeneca | Investor Event Presentation Deck | 42 slides · page 22 of 42
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.
Conference presentation · before_after · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 chart 1/1 source-note 1/1 table 1/1 title 2/2
Components 6
primary line source-note data headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1